Victorian PrEP Accord and Double Happiness

DOUBLE Happiness is the new campaign to promote the Treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) in the fight against HIV.

The Victorian PrEP Accord launched the Double Happiness Campaign with Victorian Health Minister Jill Hennessy yesterday.

The campaign uses Chinese symbolism for ‘double happiness’ to promote the union of the two complementary strategies working together: the use of anti-retroviral drugs for people living with HIV to reduce the HIV viral load to an ‘undetectable’ level (TasP), and the use of anti-retroviral drugs taken by HIV negative person to prevent HIV transmission (PrEP).

At present, the drug Truvada has been approved by the Therapeutic Goods Administration (TGA) for PrEP use, however it has not yet been listed on Pharmaceutical Benefits Scheme (PBS).

“I – along with all Australian health ministers – am committed to the goal of the virtual elimination of new HIV transmissions by 2020,” said Minister Hennessy.

Phillip Joffe chair of PrEPaccessNOW said while progress has been made in the reduction of new HIV transmission, it’s not enough.

“The quick access and availability of this drug (PrEP) is imperative to the health and wellbeing of Australians at risk for HIV.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below